Literature DB >> 22349065

Clinical characteristics and prognosis of chronic pulmonary aspergillosis.

Hisano Ohba1, Seiichi Miwa, Masahiro Shirai, Miho Kanai, Tatsuru Eifuku, Takafumi Suda, Hiroshi Hayakawa, Kingo Chida.   

Abstract

BACKGROUND: The details of the clinical characteristics of patients with chronic pulmonary aspergillosis (CPA) have not been fully understood.
METHOD: One hundred twenty-nine consecutive patients with isolation of Aspergillus species by culture from respiratory specimens who attended our hospital between October 2001 and September 2009 were enrolled. Patients diagnosed with chronic pulmonary aspergillosis (CPA) were retrospectively reviewed for clinical characteristics and prognosis, compared with patients with Aspergillus species colonization.
RESULTS: Forty-two (32.6%) were diagnosed with CPA, whereas 87 (67.4%) with colonization. Aspergillus fumigatus was significantly more frequently detected in the CPA group than in the colonization group. Regarding underlying diseases, CPA patients had a significantly higher prevalence of a history of pulmonary tuberculosis and diabetes mellitus than colonization patients. There were no significant differences between the CPA and colonization group in Aspergillus antigen titers. Positivity for Aspergillus precipitating antibody was 74.3% in CPA and 15.8% in colonization, respectively. Sensitivity and specificity of Aspergillus precipitating antibody for the determination of CPA was 74.4% and 84.1%, respectively.Patients with CPA had significantly shorter survival than patients with colonization (mortality rate 50.0% vs. 13.8%, observation periods: 28.7 ± 26.6 months) (p < 0.0001). Multivariable analysis revealed that BMI was an independent predictor of prognosis (Odds Ratio, 1.973; p = 0.0223).
CONCLUSIONS: CPA is a disease with a poor prognosis, which shows distinct clinical characteristics from colonization.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349065     DOI: 10.1016/j.rmed.2012.01.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  35 in total

1.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

2.  Effect of rifampin and rifabutin on serum itraconazole levels in patients with chronic pulmonary aspergillosis and coexisting nontuberculous mycobacterial infection.

Authors:  Seong Mi Moon; Hye Yun Park; Byeong-Ho Jeong; Kyeongman Jeon; Soo-Youn Lee; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

3.  Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.

Authors:  Naohisa Urabe; Susumu Sakamoto; Go Sano; Junko Suzuki; Akira Hebisawa; Yasuhiko Nakamura; Kazuya Koyama; Yoshikazu Ishii; Kazuhiro Tateda; Sakae Homma
Journal:  J Clin Microbiol       Date:  2017-03-22       Impact factor: 5.948

Review 4.  Chronic Aspergillosis of the Lungs: Unravelling the Terminology and Radiology.

Authors:  S R Desai; V Hedayati; K Patel; D M Hansell
Journal:  Eur Radiol       Date:  2015-03-20       Impact factor: 5.315

Review 5.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743

6.  Monaldi cavernostomy for lung aspergillosis: A case report.

Authors:  Cornel Petreanu; Alina Croitoru; Alexandru Gibu; Alexandru Zariosu; Nicolae Bacalbasa; Irina Balescu; Camelia Diaconu; Ovidiu Stiru; Mihai Dimitriu; Dragos Cretoiu; Cornel Savu
Journal:  Exp Ther Med       Date:  2021-07-06       Impact factor: 2.447

7.  The scab-like sign: A CT finding indicative of haemoptysis in patients with chronic pulmonary aspergillosis?

Authors:  Haruka Sato; Fumito Okada; Shunro Matsumoto; Hiromu Mori; Junji Kashiwagi; Eiji Komatsu; Toru Maeda; Haruto Nishida; Tsutomu Daa; Satoshi Ohtani; Kenji Umeki; Masaru Ando; Junichi Kadota
Journal:  Eur Radiol       Date:  2018-05-03       Impact factor: 7.034

8.  Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis.

Authors:  Satoru Fujiuchi; Yuka Fujita; Hokuto Suzuki; Kazushi Doushita; Hikaru Kuroda; Masaaki Takahashi; Yasuhiro Yamazaki; Tadakatsu Tsuji; Toshiaki Fujikane; Shinobu Osanai; Takaaki Sasaki; Yoshinobu Ohsaki
Journal:  J Clin Microbiol       Date:  2016-03-23       Impact factor: 5.948

9.  A DECADE TREND OF MULTIDRUG RESISTANT TUBERCULOSIS IN SÃO PAULO STATE, BRAZIL.

Authors:  Valdes Roberto Bollela; Fernanda Guioti Puga; Maria Janete Moya; Mauro Andrea; Maria de Lourdes Viude Oliveira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

10.  In vitro antifungal susceptibility of yeasts and molds isolated from sputum of tuberculosis relapse and retreatment patients.

Authors:  Josephat Tonui; Marianne Mureithi; Walter Jaoko; Christine Bii
Journal:  Pan Afr Med J       Date:  2021-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.